Literature DB >> 19726494

Development of predictive models for airflow obstruction in alpha-1-antitrypsin deficiency.

P J Castaldi1, D L DeMeo, D M Kent, E J Campbell, A F Barker, M L Brantly, E Eden, N G McElvaney, S I Rennard, J M Stocks, J K Stoller, C Strange, G Turino, R A Sandhaus, J L Griffith, E K Silverman.   

Abstract

Alpha-1-antitrypsin deficiency is a genetic condition associated with severe, early-onset chronic obstructive pulmonary disease (COPD). However, there is significant variability in lung function impairment among persons with the protease inhibitor ZZ genotype. Early identification of persons at highest risk of developing lung disease could be beneficial in guiding monitoring and treatment decisions. Using a multicenter, family-based study sample (2002-2005) of 372 persons with the protease inhibitor ZZ genotype, the authors developed prediction models for forced expiratory volume in 1 second (FEV(1)) and the presence of severe COPD using demographic, clinical, and genetic variables. Half of the data sample was used for model development, and the other half was used for model validation. In the training sample, variables found to be predictive of both FEV(1) and severe COPD were age, sex, pack-years of smoking, bronchodilator responsiveness, chronic bronchitis symptoms, and index case status. In the validation sample, the predictive model for FEV(1) explained 50% of the variance in FEV(1), and the model for severe COPD exhibited excellent discrimination (c statistic = 0.88).

Entities:  

Mesh:

Year:  2009        PMID: 19726494      PMCID: PMC2765363          DOI: 10.1093/aje/kwp216

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  38 in total

1.  Will genetics revolutionize medicine?

Authors:  N A Holtzman; T M Marteau
Journal:  N Engl J Med       Date:  2000-07-13       Impact factor: 91.245

2.  Sample size requirements for association studies of gene-gene interaction.

Authors:  W James Gauderman
Journal:  Am J Epidemiol       Date:  2002-03-01       Impact factor: 4.897

3.  Commentary: facing the challenge of gene-environment interaction: the two-by-four table and beyond.

Authors:  L D Botto; M J Khoury
Journal:  Am J Epidemiol       Date:  2001-05-15       Impact factor: 4.897

4.  COPD and declining FEV1--time to divide and conquer?

Authors:  John J Reilly
Journal:  N Engl J Med       Date:  2008-10-05       Impact factor: 91.245

5.  Alpha-1-antitrypsin deficiency: smoking, decline in lung function and implications for therapeutic trials.

Authors:  D C S Hutchison; D Cooper
Journal:  Respir Med       Date:  2002-11       Impact factor: 3.415

6.  Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry.

Authors:  Edward Eden; Jeffrey Hammel; Farshid N Rouhani; Mark L Brantly; Alan F Barker; A Sonia Buist; Robert J Fallat; James K Stoller; Ronald G Crystal; Gerard M Turino
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

Review 7.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary.

Authors:  R A Pauwels; A S Buist; P M Calverley; C R Jenkins; S S Hurd
Journal:  Am J Respir Crit Care Med       Date:  2001-04       Impact factor: 21.405

8.  Epidemiology Standardization Project (American Thoracic Society).

Authors:  B G Ferris
Journal:  Am Rev Respir Dis       Date:  1978-12

Review 9.  Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.

Authors:  M Luisetti; N Seersholm
Journal:  Thorax       Date:  2004-02       Impact factor: 9.139

10.  Tumor necrosis factor-alpha +489G/A gene polymorphism is associated with chronic obstructive pulmonary disease.

Authors:  Mehmet Küçükaycan; Michiel Van Krugten; Herman-Jan Pennings; Tom W J Huizinga; Wim A Buurman; Mieke A Dentener; Emiel F M Wouters
Journal:  Respir Res       Date:  2002-11-29
View more
  15 in total

1.  Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.

Authors:  Adam Wanner; Stephen C Groft; J Russell Teagarden; Jeffrey Krischer; Barry R Davis; Christopher S Coffey; David H Hickam; Jeffrey Teckman; David R Nelson; Michael L McCaleb; Rohit Loomba; Charlie Strange; Robert A Sandhaus; Mark Brantly; Jonathan M Edelman; Albert Farrugia
Journal:  Chronic Obstr Pulm Dis       Date:  2015-04-28

Review 2.  Why is Disease Penetration So Variable? Role of Genetic Modifiers of Lung Function in Alpha-1 Antitrypsin Deficiency.

Authors:  Brian D Hobbs; Michael H Cho
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

3.  A predictive model for the development of chronic obstructive pulmonary disease.

Authors:  Y I Guo; Yanrong Qian; Y I Gong; Chunming Pan; Guochao Shi; Huanying Wan
Journal:  Biomed Rep       Date:  2015-08-05

Review 4.  Recent advancements in understanding the genetic involvement of alpha-1 antitrypsin deficiency associated lung disease: a look at future precision medicine approaches.

Authors:  Auyon J Ghosh; Brian D Hobbs
Journal:  Expert Rev Respir Med       Date:  2022-01-13       Impact factor: 3.772

Review 5.  Alpha-1 Antitrypsin Investigations Using Animal Models of Emphysema.

Authors:  Kevin Ni; Karina A Serban; Chanan Batra; Irina Petrache
Journal:  Ann Am Thorac Soc       Date:  2016-08

Review 6.  Why is Disease Penetration so Variable in Alpha-1 Antitrypsin Deficiency? The Contribution of Environmental Factors.

Authors:  Madhu Rangaraju; Alice M Turner
Journal:  Chronic Obstr Pulm Dis       Date:  2020-07

Review 7.  Genes and chronic obstructive pulmonary disease.

Authors:  Marilyn G Foreman; Michael Campos; Juan C Celedón
Journal:  Med Clin North Am       Date:  2012-03-06       Impact factor: 5.456

8.  The Effects of Rare SERPINA1 Variants on Lung Function and Emphysema in SPIROMICS.

Authors:  Victor E Ortega; Xingnan Li; Wanda K O'Neal; Lela Lackey; Elizabeth Ampleford; Gregory A Hawkins; Philip J Grayeski; Alain Laederach; Igor Barjaktarevic; R Graham Barr; Christopher Cooper; David Couper; MeiLan K Han; Richard E Kanner; Eric C Kleerup; Fernando J Martinez; Robert Paine; Stephen P Peters; Cheryl Pirozzi; Stephen I Rennard; Prescott G Woodruff; Eric A Hoffman; Deborah A Meyers; Eugene R Bleecker
Journal:  Am J Respir Crit Care Med       Date:  2020-03-01       Impact factor: 21.405

9.  Alpha-1 antitrypsin deficiency in the elderly: a case report.

Authors:  Anna Annunziata; Maurizia Lanza; Antonietta Coppola; Giuseppe Fiorentino
Journal:  J Med Case Rep       Date:  2021-05-10

10.  A systematic analysis of protein-altering exonic variants in chronic obstructive pulmonary disease.

Authors:  Matthew Moll; Victoria E Jackson; Bing Yu; Megan L Grove; Stephanie J London; Sina A Gharib; Traci M Bartz; Colleen M Sitlani; Josée Dupuis; George T O'Connor; Hanfei Xu; Patricia A Cassano; Bonnie Kaufmann Patchen; Woo Jin Kim; Jinkyeong Park; Kun Hee Kim; Buhm Han; R Graham Barr; Ani Manichaikul; Jennifer N Nguyen; Stephen S Rich; Lies Lahousse; Natalie Terzikhan; Guy Brusselle; Phuwanat Sakornsakolpat; Jiangyuan Liu; Christopher J Benway; Ian P Hall; Martin D Tobin; Louise V Wain; Edwin K Silverman; Michael H Cho; Brian D Hobbs
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-28       Impact factor: 6.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.